Drug Resistance Updates
Volume 1, Issue 6 , Pages 377-388, 1998

Anti-growth factor therapy for lung cancer

  • Daniel C. Chan

      Affiliations

    • Lung Cancer Program and Department of Medicine, University of Colorado Cancer Center, Denver, CO, USA
    • Carcinex Inc., Boulder, CO, USA
    • ,
  • Mark Geraci

      Affiliations

    • Lung Cancer Program and Department of Medicine, University of Colorado Cancer Center, Denver, CO, USA
    • ,
  • Paul A Bunn Jr

      Affiliations

    • Lung Cancer Program and Department of Medicine, University of Colorado Cancer Center, Denver, CO, USA
    • Corresponding Author InformationCorrespondence to: Paul A Bunn Jr MD, University of Colorado Cancer Center, Box B188, 4200 E 9th Ave, Denver, CO 80262, USA. Tel: 303-315-3007, Fax: 303-315-3004

Received 31 August 1998; received in revised form 9 October 1998; accepted 12 October 1998.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1368-7646(98)80013-7

Drug Resistance Updates
Volume 1, Issue 6 , Pages 377-388, 1998

Article Tools